UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stock Holdings in HCA Healthcare, Inc. $HCA

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 17.0% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,244,576 shares of the company’s stock after selling 255,424 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in HCA Healthcare were worth $485,248,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in HCA. BlackRock Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. State Street Corp raised its position in HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares during the period. Capital World Investors boosted its holdings in shares of HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the period. Wellington Management Group LLP increased its position in HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 7th. Cantor Fitzgerald reduced their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research report on Monday, July 27th. Morgan Stanley decreased their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Finally, TD Cowen reduced their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Trading Down 0.1%

Shares of HCA stock opened at $417.57 on Monday. The stock has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.45 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock has a fifty day simple moving average of $401.08 and a two-hundred day simple moving average of $441.07.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm earned $6.84 earnings per share. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. Research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.